Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis

Pediatr Diabetes. 2010 Jun;11(4):227-34. doi: 10.1111/j.1399-5448.2009.00575.x. Epub 2009 Aug 25.

Abstract

Background/objective: Chronic pancreatitis (CP) in children is associated with significant morbidity and can lead to narcotic dependence. Total pancreatectomy (TP) may be indicated in refractory CP to relieve pain; simultaneous islet autotransplant (IAT) may prevent postsurgical diabetes. About half of pediatric patients are insulin independent 1 yr after IAT. Insulin independence correlates best with the number of islets available for transplantation (islet yield). Currently there is no known method to predict islet yield in a given patient. We assessed the ability of preoperative metabolic tests to predict islet yields in 10 children undergoing TP/IAT.

Design/methods: Hemoglobin A1c (HbA(1c)) and mixed meal tolerance tests (MMTT) were obtained prior to surgery in 10 patients age <or= 18 yr. Fasting glucose, C-peptide, and creatinine were used to calculate the C-peptide to glucose* creatinine ratio (CPGCR). C-peptide peak and area under the curve (AUC) were determined from 2 h MMTT. Linear regressions were performed to predict islet yield from baseline test results.

Results: Islet yield ranged from 7000 to 434 000 islet equivalents (IE) (mean 222 452 +/- 148 697 IE). Islet yield was well predicted from body weight and fasting plasma glucose (R (2) = 57%, adjusted for overfitting by bootstrap). Islet yield was positively associated with CPGCR, peak C-peptide, and AUC C-peptide and negatively associated with HbA(1c).

Conclusions: Pilot data from 10 pediatric patients suggest that simple preoperative measurement of fasting plasma glucose may give a useful prediction of islet yield. Islet yield correlates with HbA(1c) and C-peptide levels. This information allows individual candidates to weigh the specific risk of becoming diabetic against the benefit of pain relief should they undergo TP-IAT.

MeSH terms

  • Adolescent
  • Blood Glucose / analysis
  • C-Peptide / blood
  • Carrier Proteins / genetics
  • Child
  • Child, Preschool
  • Creatinine / blood
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Diabetes Mellitus, Type 1 / prevention & control
  • Fasting
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Islets of Langerhans Transplantation*
  • Islets of Langerhans*
  • Male
  • Pain, Intractable / surgery
  • Pancreatectomy*
  • Pancreatitis, Chronic / genetics
  • Pancreatitis, Chronic / mortality
  • Pancreatitis, Chronic / surgery*
  • Prospective Studies
  • Transplantation, Autologous
  • Treatment Outcome
  • Trypsin / genetics
  • Trypsin Inhibitor, Kazal Pancreatic

Substances

  • Blood Glucose
  • C-Peptide
  • CFTR protein, human
  • Carrier Proteins
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • SPINK1 protein, human
  • hemoglobin A1c protein, human
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Trypsin Inhibitor, Kazal Pancreatic
  • Creatinine
  • PRSS1 protein, human
  • Trypsin